Kelyniam Global, Inc. (KLYG) Stock

About Kelyniam Global, Inc.

Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced medical-grade polymers. Additionally, Kelyniam develops, produces, and supplies specific cranial and craniofacial fixation screws, crucial for the reconstruction of skull and facial structures. Its clientele encompasses health systems, hospitals, sales representatives, surgeons, insurance providers (payors), and individual patients. Established in 2005, the company was originally named Ketner Global Investments, Inc., rebranding to Kelyniam Global, Inc. in December 2007. Kelyniam Global is based in Collinsville, Connecticut.

Kelyniam Global, Inc. is headquartered in US.

Kelyniam Global, Inc. (KLYG) stock trades at $0.13 with a market capitalization of $1.65M. The stock is valued at a price-to-earnings (P/E) ratio of -187.40, price-to-book of 8.62, price-to-sales of 0.46. Over the past 52 weeks the stock has ranged between $0.05 and $0.30, and currently trades 56.7% below its 52-week high.

On profitability, Kelyniam Global, Inc. generates a return on equity (ROE) of -4.32%, return on capital employed of 32.74%, an operating margin of 8.91%, a net profit margin of -0.91%.

Official website: www.kelyniam.com